The CADF checks that all the results are correctly uploaded into ADAMS by the WADA-accredited laboratories and conducts a preliminary results management assessment in case of Atypical (ATF) or Adverse Analytical Findings (AAF). If the case amounts to a potential Anti-Doping Rule Violation (ADRV), the CADF forwards the case to the UCI Legal Anti-Doping Services (LADS) for further action.

CADF also forwards Adverse Passport Findings and potential non-analytical breaches of the Anti-Doping Rules to LADS for further action. The most common scenarios are listed below.

• A WADA-accredited laboratory reports an AAF into ADAMS and the rider has no authorisation for use of the prohibited substance for therapeutic purposes (TUE).
• Three independent experts unanimously come to conclusion that, considering the available information contained within an Athlete Biological Passport (ABP), it is highly likely that a prohibited substance or method has been used, and highly unlikely that the ABP is the result of any other cause, an Adverse Passport Finding is reported to CADF by the Athlete Passport Management Unit (APMU) in Lausanne.
• A rider provides erroneous information on his or her location such that the anti-doping official cannot carry out an out-of-competition control, or the rider provides whereabouts information after the deadline: this is known as a whereabouts failure. All potential whereabouts failures are passed on to the LADS for further action.
• A rider does not submit to a control (cannot be found, disappears, refuses to submit to the test, etc.): this behavior is reported to the CADF by the anti-doping official or the relevant party. The CADF examines the potential breach, gathers the necessary information and passes on the file of the potential ADRV to LADS for further action.
• A rider attempts to manipulate a control (e.g. by using techniques that seek to falsify the sample or even by intentionally destroying the sample). Facts are reported to CADF, which compiles a file, and passed on to the LADS.
• The final scenario concerns the administration, possession or trafficking of prohibited substances. Anyone (e.g. whistleblower), any organization, including National Anti-Doping Organizations, WADA or civil authorities (e.g. law enforcement) may assist CADF in investigating and determining whether there is reasonable cause to suspect that an ADRV may have been committed.